A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica

Clinical trial NCT04800562 · TERMINATED

Trial details

NCT number: NCT04800562
Sponsor: Processa Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Necrobiosis Lipoidica

Start date: 2021-04-12
Primary completion: 2023-02-28
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.